<DOC>
	<DOC>NCT02609867</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and short-term effectiveness of implantation of 'Flowise Cerebral Flow Diverter' for the treatment of unruptured wide-necked cerebral aneurysm in the internal carotid artery.</brief_summary>
	<brief_title>A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise)</brief_title>
	<detailed_description>Flowise is indicated for use in patients with unruptured wide-necked aneurysm in the internal carotid artery. Consecutive subject data should be collected at discharge, 1, 3, and 6 month post Flowise implantation.</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Functional neurological state ≤2 mRS Unruptured wideneck aneurysm in the internal carotid artery has a size &gt;8mm, a neck ≥4mm, or dome/neck ratio &lt;2 Parent artery with diameter ≥3.25mm and ≤4.5mm Patient willing to provide written informed consent and comply with followup requirements Intracranial hemorrhage within 30 days Untreated ruptured intracranial aneurysm ≥1 intracranial aneurysm except the target one requires treatment within 6 months Immunosuppressive disease Active infectious disease (e.g. endocarditis, meningitis) Platelet count &lt; 100 x 103 cells/mm3 Female of childbearing potential who are unable to take adequate contraceptive precautions, are known to be pregnant, or are currently breastfeeding an infant.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>